Facilitating Cardiology Decision-making at the Point-of-care
As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge…
As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge…
Getting the right medicine into the hands of a patient in a timely manner has always been the ultimate goal…
In this article, Sarah Ray, Senior Research Analyst, explores the following issue: amidst a regulatory environment which increasingly focuses on…
A Two-step Pre-screening Process Before Site Referral Improves Efficiency and Reduces Costs Clinical trial recruitment involves three distinct phases: (1)…
According to this article from Charlotte Housden, Head of the Biotechnology and Research Business Unit at Cambridge Cognition, there is…
Riin Ehin, Chairwoman of the Board and CEO of Competence Centre for Cancer Research, partner and CEO of Bravo Healthcare…
As Markku Toivonen, MD, PhD, chairman of CHMP Scientific Advice Working Party, explains in this piece, according to current evidence,…
Mona Dawood, Head of the Pharmaceutical Operations & Regulatory Affairs for CIDP Group, provides an insightful report on Singapore, a…
With the growth of comparative effectiveness research (CER) and the need for large volumes of active comparator medicines comes an…
Each year, Veeva surveys the pharmaceutical industry on its use of trial master file (TMF) processes. Within this article, Rik…